Letter to the Editor regarding "Ophthalmic artery angioplasty for age-related macular degeneration"
- PMID: 35318958
- DOI: 10.1136/neurintsurg-2022-018750
Letter to the Editor regarding "Ophthalmic artery angioplasty for age-related macular degeneration"
Keywords: Angioplasty; Artery.
Conflict of interest statement
Competing interests: GQ is a consultant for Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc. (Irvine, California, USA), Bayer Schering Pharma (Berlin, Germany), Heidelberg Engeneering (Germany), Novartis (Basel, Switzerland), Sandoz (Berlin, Germany), Zeiss (Dublin, California, USA).
Comment in
-
Reply to Letter to the Editor regarding "Ophthalmic artery angioplasty for age-related macular degeneration".J Neurointerv Surg. 2022 Oct;14(10):1047. doi: 10.1136/neurintsurg-2022-018836. Epub 2022 Mar 22. J Neurointerv Surg. 2022. PMID: 35318961 No abstract available.
Comment on
-
Ophthalmic artery angioplasty for age-related macular degeneration.J Neurointerv Surg. 2022 Oct;14(10):968-972. doi: 10.1136/neurintsurg-2021-018222. Epub 2022 Jan 5. J Neurointerv Surg. 2022. PMID: 34987072 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical